Niche-targeted paracrine signaling from OMSCs restores the regenerative microenvironment after SCI
Source abstract
Abstract
Abstract A central hurdle in spinal cord injury (SCI) therapy involves not only reconstructing neural pathways but also overcoming the detrimental inflammatory milieu. Inspired by olfactory microenvironmental niches, we implemented a niche-targeted strategy. Our investigation defines the biological properties of ectodermal olfactory mesenchymal stem cells (OMSCs) and further elucidates their niche-targeted paracrine effect in vivo and in vitro . The findings demonstrate that OMSC-conditioned medium (OMSC-CM) delivered in fibrin hydrogel mediates potent SCI repair by concurrently protecting neurons, enhancing axonal regeneration, and suppressing destructive inflammation via IL-10 signaling. Critically, persistence of IL-10 signaling in vivo is sustained both by direct supply from OMSC-CM and by OMSC-CM-induced activation of CD206 + macrophages IL−10 . Successful neural circuit reconstruction with OMSC-CM depends on maximizing neuronal involvement in neural pathway formation. These findings may establish a special conceptual framework for developing regenerative medicine strategies in the future.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nerve injury and regeneration · Neurogenesis and neuroplasticity mechanisms · Mesenchymal stem cell research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (58)
Show source-provided references
1. Exosomes: a promising microenvironment modulator for spinal cord injury treatment10.7150/ijbs.115242 ↗
2. Functional biomaterials for modulating the dysfunctional pathological microenvironment of spinal cord injury10.1016/j.bioactmat.2024.04.015 ↗
3. Olfactory receptors in neural regeneration in the central nervous system10.4103/NRR.NRR-D-24-00495 ↗
4. Neuronal plasticity and regeneration in the olfactory system of mammals: morphological and functional recovery following olfactory bulb deafferentation10.1007/PL00000879 ↗
5. Adult neurogenesis and the olfactory system10.1016/j.pneurobio.2009.07.003 ↗
6. Olfactory mucosa: a rich source of cell therapy for central nervous system repair10.1515/revneuro-2014-0065 ↗
7. Adult human nasal mesenchymal stem cells have an unexpected broad anatomic distribution10.1002/alr.21153 ↗
8. Isolation and characterization of cat olfactory ecto-mesenchymal stem cells10.3390/ani12101284 ↗
9. Human nasal olfactory stem cells, purified as advanced therapy medicinal products, improve neuronal differentiation10.3389/fnins.2022.1042276 ↗
10. Isolation and characterization of olfactory ecto-mesenchymal stem cells from eight mammalian genera10.1186/s12917-018-1342-2 ↗
11. Mesenchymal stromal cell-based products: challenges and clinical therapeutic options10.3390/ijms25116063 ↗
12. Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: risk-benefit profile and next steps for the market access10.1016/j.bioactmat.2023.06.013 ↗
13. Mesenchymal stem cell secretome for regenerative medicine: where do we stand?10.1016/j.jare.2024.05.004 ↗
14. Myostatin regulates energy homeostasis through autocrine- and paracrine-mediated microenvironment communication10.1172/JCI178303 ↗
15. Localized GLP1 receptor pre-internalization directs pancreatic alpha cell to beta cell communication10.1016/j.cmet.2025.06.009 ↗
16. Cancer neuroscience: state of the field, emerging directions10.1016/j.cell.2023.02.002 ↗
17. Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells10.1038/s41584-023-01010-7 ↗
18. Effects of mesenchymal stem cell-derived paracrine signals and their delivery strategies10.1002/adhm.202001689 ↗
19. Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration10.1186/s12967-021-03125-5 ↗
20. Microelectrode arrays measure blocking of voltage-gated calcium ion channels on supported lipid bilayers derived from primary neurons10.1002/advs.202304301 ↗
21. Fisetin promotes functional recovery after spinal cord injury by inhibiting microglia/macrophage M1 polarization and JAK2/STAT3 signaling pathway10.1021/acs.jafc.4c02985 ↗
22. LBO-EMSC hydrogel serves a dual function in spinal cord injury restoration via the PI3K-Akt-mTOR pathway10.1021/acsami.1c12013 ↗
23. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains10.1089/neu.2006.23.635 ↗
24. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement10.1080/14653240600855905 ↗
25. The stem cell-specific intermediate filament nestin missense variation p.A1199P is associated with pancreatic cancer10.3892/ol.2019.10106 ↗
26. Nestin regulates proliferation, migration, invasion and stemness of lung adenocarcinoma10.3892/ijo.2014.2278 ↗
27. Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeutics10.1016/j.jcyt.2024.10.008 ↗
28. PC-12 cell line as a neuronal cell model for biosensing applications10.3390/bios12070500 ↗
29. Blood-spinal cord barrier in spinal cord injury: a review10.1089/neu.2020.7413 ↗
30. Autologous fibrin glue: the last step in operative hemostasis10.1016/S0002-9610(94)80049-9 ↗
31. The role of inflammatory cascade and reactive astrogliosis in glial scar formation post-spinal cord injury10.1007/s10571-024-01519-9 ↗
32. The role of Interleukin-10 in the pathogenesis and treatment of a spinal cord injury10.3390/diagnostics14020151 ↗
33. Advances in the research of the role of macrophage/microglia polarization-mediated inflammatory response in spinal cord injury10.3389/fimmu.2022.1014013 ↗
34. NT3-chitosan elicits robust endogenous neurogenesis to enable functional recovery after spinal cord injury10.1073/pnas.1510194112 ↗
35. Remodeling microenvironment for endogenous repair through precise modulation of chondroitin sulfate proteoglycans following spinal cord injury10.1002/smll.202205012 ↗
36. Contribution of olfactory neural stem cells to tissue maintenance and regeneration10.1038/nn1882 ↗
37. Stem and progenitor cells of the mammalian olfactory epithelium: taking poietic license10.1002/cne.24105 ↗
38. Olfactory mucosa for transplant-mediated repair: a complex tissue for a complex injury10.1002/glia.20917 ↗
39. Secretome of olfactory mucosa mesenchymal stem cell, a multiple potential stem cell10.1155/2016/1243659 ↗
40. Differential expression of CXCL12 and CXCR4 during human fetal neural progenitor cell differentiation10.1007/s11481-007-9081-3 ↗
41. Chemokine signaling is required for homeostatic and injury-induced neurogenesis in the olfactory epithelium10.1002/stem.3338 ↗
42. Nestin-expressing progenitor cells: function, identity and therapeutic implications10.1007/s00018-018-2794-z ↗
43. Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration10.1186/s12974-021-02337-2 ↗
44. Interleukin-10 signaling in somatosensory neurons controls CCL2 release and inflammatory response10.1016/j.bbi.2023.12.013 ↗
45. Restoration of motor function through delayed intraspinal delivery of human IL-10-encoding nucleoside-modified mRNA after spinal cord injury10.34133/research.0056 ↗
46. A DAMP-scavenging, IL-10-releasing hydrogel promotes neural regeneration and motor function recovery after spinal cord injury10.1016/j.biomaterials.2021.121279 ↗
47. Interleukin-10 genetically modified clinical-grade mesenchymal stromal cells markedly reinforced functional recovery after spinal cord injury via directing alternative activation of macrophages10.1186/s11658-022-00325-9 ↗
48. Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair10.1016/j.tins.2012.06.003 ↗
49. Comparison of mesenchymal stromal cells isolated from murine adipose tissue and bone marrow in the treatment of spinal cord injury10.1177/0963689718780309 ↗
50. Prospect of stem cell conditioned medium in regenerative medicine10.1155/2014/965849 ↗
51. Conditioned medium—is it an undervalued lab waste with the potential for osteoarthritis management10.1007/s12015-023-10517-1 ↗
52. Hitting the target: cell signaling pathways modulation by extracellular vesicles10.20517/evcna.2024.16 ↗
53. Exosome-based therapy for spinal cord injury: a narrative review10.4103/ATN.ATN-D-25-00001 ↗
54. Stem cell-derived extracellular vesicle-mediated therapeutic signaling in spinal cord injury10.3390/ijms26020723 ↗
55. Therapeutic potential of mesenchymal stem cell-derived exosomes in spinal cord injury10.1007/s12035-024-04490-0 ↗
56. Inhibition of ferroptosis by mesenchymal stem cell-derived exosomes in acute spinal cord injury: role of Nrf2/GCH1/BH4 axis10.14245/ns.2448038.019 ↗
57. Application and mechanism of cell therapy technology in the repair of spinal cord injury: a narrative review10.4103/ATN.ATN-D-24-00008 ↗
58. Engineering multifunctional adhesive hydrogel patches for biomedical applications10.1002/INMD.20230008 ↗